NHS Digital launches National Record Locator Service
NHS Digital has taken an important step towards a more integrated health and care system with the launch of the new National Record Locator...
Major milestone in Unified Data Model project to promote life sciences collaboration
The Pistoia Alliance has announced a major milestone in Unified Data Model project to promote life sciences collaboration. The Pistoia Alliance, a global, not-for-profit alliance...
European Commission grants marketing authorisation for Sandoz biosimilar Ziextenzo ® (pegfilgrastim)
European Commission grants marketing authorisation for Sandoz biosimilar Ziextenzo ® (pegfilgrastim). Sandoz, a Novartis division, has announced that the European Commission (EC) has granted marketing authorisation...
Shionogi Ltd appoints Star for UK launch
Star is delighted to be partnering with specialist research-driven Japanese pharma company, Shionogi & Co., Ltd., as they launch a new product into the...
EC approve Pelmeg▼® for chemotherapy induced neutropenia
European Commission (EC) has granted approval for the use of Pelmeg (pegfilgrastim) as a treatment for chemotherapy induced neutropenia. The Mundipharma network of independent associated...
Strong painkillers increase hip fracture risk in Alzheimer’s patients
People with Alzheimer's disease using strong opioid painkillers have twice the risk of hip fracture compared to non-opioid users, according to a new study. The...
Autoimmune conditions costing UK billions each year
A report has revealed that rapidly rising rates of autoimmune conditions are costing the UK billions each year. The report, from Connect Immune Research, a...
NHS negotiates deals on adalimumab biosimilars
The NHS negotiates deals on adalimumab biosimilars which could save £300 million. Simon Stevens has announced that the NHS is set to save a record £300...
PPRS replacement will offer faster access to new medicines and save money
The new PPRS replacement could see patients have faster access to new medicines, up to six months earlier, in a deal expected to save...
Camurus recieves EU marketing authorisation for Buvidal ®
Camurus has announced that the European Commission has granted marketing authorisation for Buvidal. Buvidal® (CAM2038), the first and only long-acting injectable treatment available in both weekly...
Latest articles
Maxwellia expand their team with two new appointments
Maxwellia has expanded their team of switch experts with two new appointments following their relocation to the Alderley Park Accelerator.
BMS & Boston Medical Center announce research collaboration
BMS & Boston Medical Center enter research collaboration to investigate markers of immuno-oncology response and resistance Bristol-Myers Squibb Company...
EC approves KEYTRUDA® as adjuvant therapy
MSD (Merck in the U.S. and Canada) has announced that the European Commission has approved its anti-PD-1 therapy, KEYTRUDA (pembrolizumab), for the adjuvant treatment...